Cart
sales@molnova.com
4-Chlorosalicylic acid
CAS No. 5106-98-9
4-Chlorosalicylic acid( —— )
Catalog No. M14758 CAS No. 5106-98-9
Antimicrobial compositions comprising a benzoic acid analog and a metal salt.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | 27 | In Stock |
|
Biological Information
-
Product Name4-Chlorosalicylic acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionAntimicrobial compositions comprising a benzoic acid analog and a metal salt.
-
DescriptionAntimicrobial compositions comprising a benzoic acid analog and a metal salt.
-
In Vitro4-chlorosalicylic acid could inhibit both the diphenolase activity and the monophenolase activity of mushroom tyrosinase. 4-chlorosalicylic acid has broad-spectrum antimicrobial activity which could inhibits Gram-positive and Gram-negative bacteria and fungi.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number5106-98-9
-
Formula Weight172.57
-
Molecular FormulaC7H5ClO3
-
Purity>98% (HPLC)
-
SolubilityLimited solubility
-
SMILESOC(=O)C1=C(O)C=C(Cl)C=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Wei Jiang et. al. Analytical Sciences, 19(6), 923-925 (2003)
molnova catalog
related products
-
loddigesiinol A
loddigesiinol A
-
SRI-42127
SRI-42127 is a novel small molecule inhibitor of the RNA regulatory factor HuR, which inhibits tumor growth, attenuates glial activation in a lipopolysaccharide-induced neuroinflammation model, and reduces neuropathic pain after nerve injury by inhibiting the neuroinflammatory response.
-
BDNF (human)
Member of the neurotrophin growth factor family that binds and activates TrkB and p75 neurotrophin receptors. Enhances the survival, growth and differentiation of neurons. BDNF expression is altered in neurodegenerative disorders such as Parkinson's and Alzheimer's disease.
